RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy
Ahlem Jebali(Inserm), Nicolas Dumaz(Inserm)
Cited by 15
Related Papers
RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma
|Oncotarget|2015|33
FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma
|Cancers|2020|9
PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors
|Cell Communication and Signaling|2024|4